Top Markets
#1 QuantixAI QuantixAI +38.69%
#2 MowCat MowCat +27.21%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +19.24%
#4 Prom Prom +17.48%
#5 Versatize Coin Versatize Coin +16.67%
#6 Tutorial Tutorial +16.27%
#7 UnifAI Network UnifAI Network +12.26%
#8 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +12.10%
#9 StonkBroker StonkBroker +11.26%
#10 Pons Pons +10.20%
Coin of the day
QuantixAI QuantixAI
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Vaxart, Inc. Vaxart, Inc.

Vaxart, Inc.

VXRT
Clasificación en acciones #20648
Vaxart, Inc. operates as a biotechnology firm currently in the clinical... Vaxart, Inc. operates as a biotechnology firm currently in the clinical development phase, concentrating its efforts on identifying and advancing novel oral recombinant protein vaccines. The company leverages its unique proprietary platform for delivering these oral vaccine solutions. Its diverse pipeline showcases several promising candidates: An oral tablet vaccine targeting norovirus, which is presently undergoing Phase Ib clinical assessment for both GI.1 and GII.4 strains. A seasonal influenza vaccine, now in Phase II clinical studies, designed to address H1 influenza infections. A vaccine candidate against respiratory syncytial virus (RSV). A coronavirus vaccine, also advancing through Phase II clinical trials for SARS-CoV-2. Beyond infectious diseases, Vaxart is also engaged in formulating therapeutic vaccines aimed at treating cervical cancer and dysplasia associated with human papillomavirus. The company's main operations are situated in South San Francisco, California.
Precio por acción
$0.517
Última sincronización: 2026-08-21
Capitalización bursátil
$125.14M
Cambio (1 día)
-0.58%
Cambio (1 año)
47.71%
País
US
Comercio Vaxart, Inc. (VXRT)

Categoría

Healthcare
EPS de Vaxart, Inc. (VXRT)
EPS a fecha de 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de Vaxart, Inc., el EPS actual de la empresa (TTM) es 0. Al final del año 2026, la empresa tenía un EPS de 0 igual a al EPS de 2026, que fue de 0.
Historial de EPS de Vaxart, Inc. desde 2026 hasta 2026
EPS al final de cada año
Año EPS Cambiar
Not enough data for the provided dates.
EPS de empresas similares o competidoras
Empresa EPS Diferencia de EPS País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH